You searched for inhaled corticosteroids

ACAAI 2022

Number of Patient-Reported Severe Asthma Triggers Predicts Morbidity

November 15, 2022

The observational study that enrolled 2847 adult patients with severe asthma receiving maintenance systemic corticosteroids, biologics, or uncontrolled on high-dosage inhaled corticosteroids and additional controllers.

CHEST 2022

Triple Therapy Linked to Fewer Exacerbations in COPD With Elevated Eosinophils

October 20, 2022

Post hoc analysis of a real-world COPD trial assessed the effect of triple therapy in reducing exacerbations in patients with higher vs lower eosinophil levels.

CHEST 2022

ICS-LABA Proved Effective in Treating Sjogren Syndrome With Bronchiolitis

October 18, 2022

Investigators explored the value of treating patients with bronchiolitis in primary Sjogren’s Syndrome using inhaled corticosteroids and long-acting beta agonists.

CHEST 2022

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

October 17, 2022

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.

CHEST 2022

Inhaled Corticosteroid Use for COPD, Asthma Does Not Affect COVID-19 Outcomes

October 17, 2022

In patients with COPD and asthma who are hospitalized for COVID-19, how does pre-hospitalization ICS use affect the clinical course of COVID-19?

CHEST 2022

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

October 17, 2022

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.

News

Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment

July 15, 2022

Finding from a nationwide study of 5,000 participants that continues to evaluate existing drugs to treat mild-to-moderate COVID-19

News

Prevalence of COVID-19-Related Croup Up During Omicron

July 6, 2022

Odds of hospitalization not significantly different during periods with alpha or other variant predominance, delta predominance, versus omicron-predominant periods

ATS 2022

How Does Omalizumab Affect Antitussive Use in Patients With Allergic Asthma?

May 17, 2022

Does omalizumab therapy for patients with moderate to severe allergic asthma affect these patients’ use of antitussives?

ATS 2022

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

May 17, 2022

For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?

Active Filters

Your search for inhaled corticosteroids returned 152 results

Sort Results:

Number of Patient-Reported Severe Asthma Triggers Predicts Morbidity

Triple Therapy Linked to Fewer Exacerbations in COPD With Elevated Eosinophils

ICS-LABA Proved Effective in Treating Sjogren Syndrome With Bronchiolitis

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

Inhaled Corticosteroid Use for COPD, Asthma Does Not Affect COVID-19 Outcomes

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment

Prevalence of COVID-19-Related Croup Up During Omicron

How Does Omalizumab Affect Antitussive Use in Patients With Allergic Asthma?

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization